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The Apolipoprotein E4 (ApoE4) allele has been suggested as the main risk factor for 
late onset Alzheimer’s disease (AD), whereas the ApoE2 allele has been proposed as a 
protective factor. These proposals have increased the interest in the effect of the ApoE 
genotype in healthy people. Additionally, high cortisol levels have been related to 
negative effects on cognition. The aim of this study was to evaluate cognition 
(declarative and working memory, attention, and executive function) and its relationship 
with cortisol, considering the ApoE2, ApoE3, and ApoE4 alleles in healthy older people 
(55-77 years old). Two saliva samples were collected during the neuropsychological 
session to obtain cortisol levels and the ApoE genotype. Results showed an association 
between the ApoE genotype and declarative memory, specifically learning ability, 
where ApoE2 performed better than ApoE4 and ApoE3. No differences in cortisol 
levels were obtained considering the ApoE genotype. In addition, higher cortisol levels 
were related to worse performance on declarative memory. Taking into account the 
three allelic variations, this association was only significant for the ApoE4 group. On 
the other hand, higher cortisol levels were related to better attention in all participants. 
Considering the ApoE groups, this association was only significant for the ApoE3 
group. Therefore, our results suggest that carrying the ApoE4 allele may be a 
vulnerability factor to the adverse effects of Hypothalamic-Pituitary-Adrenal (HPA 
axis) dysregulation on cognition during aging. 







The increase in life expectancy in our society has aroused interest in the 
biological mechanisms underlying cognition and its decline during aging 
(Payton et al., 2005). The Apolipoprotein E (ApoE) polymorphism has been proposed 
as a mediator of this age-related cognitive impairment (Helkala et al., 1996).  
The ApoE gene has three common allelic variations (Bertram, Lill, &Tanzi, 2010), with 
the ApoE 3 being the most common, with an occurrence rate of approximately 78%. By 
contrast, The ApoE2 and ApoE4 alleles are less common (8% and 14%, respectively) 
(Menzel, Kladetzky, &Assmann, 1983). The ApoE4 allele presents the main risk factor 
for late-onset AD (Bertram et al., 2010), and it has also been associated with a higher 
risk of Mild Cognitive Impairment (MCI) (Dixon et al., 2014), accelerated cognitive 
decline in normal aging (Bretsky, Guralnik, Launer, Albert, &Seeman, 2003; Caselli et 
al., 2004; 2011; Schiepers et al., 2012; Smith, 2002), and decreased longevity (Corder et 
al., 1996). By contrast, the ApoE2 allele has been associated with survival in older 
people (Corder et al., 1996) and a reduced risk of AD (Verghese, Castellano, & 
Holtzman, 2011). In addition, Farrer et al. (1997) observed that the association between 
ApoE4 and a higher risk for AD was stronger in the Caucasian population, compared to 
African Americans and Hispanics, whereas the ApoE2/E3 genotype appeared to be 
equally protective across ethnic groups. However, it is important to note that the ApoE 
gene has no effect on the risk of dementia and mortality in the oldest old (Corrada, 
Paganini-Hill, Berlau, & Kawas,  2013). 
All these findings have aroused interest in the role ApoE variants play in the 
cognitive functioning of healthy people. Several studies have found an association 
between the ApoE4 allele and worse cognitive performance (Bondi, Salmon, Monsch, 
Galasko, & Butters, 1995; Deary et al., 2004; Flory, Manuck, Ferrell, Ryan, & 
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Muldoon, 2000; Honea, Vidoni, Harsha, & Burns, 2009; Kang, Logroscino, De Vivo, 
Hunter, & Grodstein, 2005; Small, Rosnick, Fratiglioni, & Bäckman, 2004; Wilson, 
Bienias, Berry-Kravis, Evans, & Bennett, 2002). However, other studies have found no 
association (Cohen, Small, Lalonde, Friz, & Sunderland, 2001; Jorm et al., 2007; 
Lineweaver, Bondi, Galasko, & Salmon, 2014; Small et al., 2000; Smith et al., 1998), or 
even better cognitive performance (Alexander et al., 2007; Mondadori et al., 2007; 
Riley et al., 2000). These inconsistent results may be due to several factors. First, some 
studies may have included undetected preclinical cases of AD. Therefore, some of the 
ApoE4-related deficits may be attributable to an overrepresentation of preclinical cases 
of AD, rather than reflecting the effect of this allele alone (Bondi, Salmon, Galasko, 
Thomas, & Thal, 1999). In addition, due to the association between ApoE and AD, 
where declarative memory is the most affected cognitive function, most of the research 
has focused on this association, with less research carried out on working memory, 
attention, and executive function. Moreover, in most studies, the ApoE2 allele has been 
grouped within the ApoE3 homozygotes under the broad category of “ApoE4 non-
carriers” (Beluche, Carrière, Ritchie, & Ancelin, 2010; Fiocco, Poirier, Joober, Nair, & 
Lupien, 2008). Therefore, few studies have explored the effect of the ApoE4 allele 
independently from the ApoE2 effects (Lara et al., 2013). 
In addition to the effects of the ApoE, cognitive function is also influenced by 
the Hypothalamic-Pituitary-Adrenal (HPA) axis function thorough the influence of 
cortisol, the end product of HPA-axis activation, on glucocorticoid receptors located in 
the hippocampus and other brain areas. Hence, higher cortisol levels also have an 
influence on human cognition in healthy older people (Almela, van der Meij, Hidalgo, 
Villada, & Salvador, 2012; Hidalgo, Almela, Pulopulos, & Salvador, 2016; Lupien, 
Gillin, & Hauger, 1999). Increased cortisol levels are a well-established feature in AD, 
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although the mechanism responsible for HPA-axis hyperactivity is unknown (Gil-Bea et 
al., 2010; Peskind, Wilkinson, Petrie, Schellenberg, & Raskind, 2001). This fact, along 
with the evidence that ApoE4 is a risk factor for developing AD (Bertram et al., 2010), 
suggests that the ApoE gene may affect the association between the HPA-axis and 
cognitive function (Peavy et al., 2007). Moreover, similar to preclinical brain changes 
related to AD, structural and functional abnormalities of the hippocampus have been 
found in healthy ApoE4 carriers (Lu et al., 2011). Furthermore, it is worth noting that 
some results from studies in animals have found that the interaction between the ApoE4 
allele and stress could shape cognitive function (Grootendorst et al, 2002; Kloet et al., 
2002). In humans, an association between increased risk of developing PTSD and the 
ApoE4 (Roby, 2017) and ApoE2 alleles (Kim et al., 2013) has been reported; this latter 
allele has also been related to an increased susceptibility to stress-induced impairments 
in memory (Freeman, Roca, Guggenheim, Kimbrell, & Griffin, 2005) and to HPA axis 
dysregulation (Johnson et al., 2015).  
Studies in healthy people are scarce, with varying results. Some studies found an 
association for the ApoE4 allele between a HPA-axis alteration and cognitive decline 
(Gerritsen, Comijs, Deeg, Penninx, & Geerlings, 2011; Lee et al., 2008; Li et al., 2006) 
measuring salivary cortisol. However, other studies using salivary (Beluche et al., 2010; 
Li et al., 2006), serum (Lara et al., 2013; Fiocco et al., 2008) or CFS samples (Gil-Bea 
et al., 2010) to determine cortisol concentrations found no association in healthy 
individuals. Therefore, this is an issue that warrants additional research. 
With all this in mind, we aimed to examine: (i) the differences between the 
different ApoE groups in cognitive performance (i.e. declarative and working memory, 
attention, and executive function) and cortisol levels during the neuropsychological 
assessment and (ii) the relationship between cortisol and cognitive performance, taking 
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into account the ApoE groups, in non-stressed, healthy older people. To do so, a 
neuropsychological battery was administered to assess a wide range of cognitive 
functions. Based on previous literature, we hypothesized that the ApoE4 group would 
show worse cognitive performance (Honea et al., 2009; Laukka et al., 2013; Nilsson et 
al., 2006; Small et al., 2004; Wisdom, Callahan, & Hawkins, 2011), whereas the ApoE2 
group would show better performance (Verghese et al., 2011). We also hypothesized 
that there would be higher cortisol levels in the ApoE4 group compared to the ApoE2 
and ApoE3 groups. Finally, we expected to find an association between higher cortisol 
levels and worse cognitive function, especially on declarative memory, and this would 
be more pronounced in the ApoE4 group. 
 
2. Methods 
2.1. Participants   
The final sample was composed of 84 participants of both sexes (40 men and 44 
woman), ranging in age from 55 to 77 years (M= 65.18, SD= 4.631). Most of the 
participants had an educational level beyond high school (79.8%), and their subjective 
socioeconomic status was medium (M= 5.51, SD= 1.086) (subjective SES scale: Adler 
et al., 2000).  
The total sample was categorized in three groups: ApoE2 (n= 9; E2/E2=1 and 
E2/E3=8), ApoE3 (E3/E3=59), and ApoE4 (n=16; E4/E4=2 and E4/E3=14). Due to the 
small number of participants who were homozygous for the E2 and E4 allele (E2/E2=1 
and E4/E4=2), both the homozygous and heterozygous participants were grouped in the 
broad category of ApoE2 and ApoE4, respectively. The ApoE group frequencies were 
10.7 % for ApoE2, 70.2 % for ApoE3, and 19 % for ApoE4. There were no significant 
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differences among the ApoE2, ApoE3, and ApoE4 groups on sex, age, Body Mass Index 
(BMI), SES, or educational level (all p> 0.115) (Table 1). 






















52.4% 65.18 4.631 5.51 1.086 27.34 3.248 79.8% 
ApoE2 9 
(10.7%) 
55.6% 62.78 3.383 5.67 .707 27.81 2.693 77.8% 
ApoE3 59 
(70.2%) 
49.2% 65.27 4.634 5.62 1.040 27.35 3.405 81.4% 
ApoE4 16 
(19%) 
62.5% 66.19 4.996 5.00 1.317 27.09 3.050 75% 
  p= .625 p=.203  p=.115  p=.881  p=.627 
Table 1. Descriptive data for the total sample and for each ApoE group (ApoE2, 
ApoE3, and ApoE4). Age, SES (subjective socioeconomic status), and BMI (body mass 
index) are represented as mean values (M) and standard deviation (SD). Educational 
level is represented as the percentage of participants with an educational level beyond 
high school (%). Differences between ApoE status were analyzed with ANOVAs (age, 
SES, and BMI) and chi-square (sex and educational level) analyses. No differences in 
sex, age, SES, BMI, or educational level were found depending on the ApoE group (all 
p ≥ .115). 
All the women were postmenopausal and had their last menstrual period more 
than 3 years before the testing time. None of the participants scored less than 28 on the 
MEC (Spanish version of the Mini-Mental Status Examination; Lobo et al., 1999), 
indicating the absence of cognitive impairment. 
Participants were Caucasians, and they were recruited from a study program at 
the University of Valencia for people over 55 years of age. Two hundred and twenty 
volunteers were interviewed by telephone in order to check whether they met the study 
prerequisites. Exclusion criteria were: smoking more than 10 cigarettes a day, alcohol or 
other drug abuse, visual or hearing problems, diabetes, neurological or psychiatric 
disease, using any medication directly related to emotional or cognitive functioning or 
able to influence hormonal levels such as glucocorticoids, psychotropic substances, or 
sleep medications, having been under general anesthesia once or more than once in the 
past year, and the presence of a stressful life event during the past year.  
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One hundred twenty-eight individuals participated in the study, of whom thirty-seven 
were eliminated because they did not meet the inclusion or exclusion criteria: 20 
participants for using medication related to emotional or cognitive functioning or able to 
influence hormonal levels, such as glucocorticoids, psychotropic substances, or sleep 
medications; 7 participants for having diabetes; 4 participants due to severe and 
uncorrected visual or hearing problems; 4 participants for having a stressful life event 
during the past year; 1 for alcohol abuse; and 1 participant for having been under 
general anesthesia in the past year. Of the remaining ninety-one participants, the ApoE 
polymorphism of three participants could not be genotyped, and one participant was 
excluded for being ApoE2/E4. Finally, after dividing the sample according to the ApoE 
genotype (ApoE2, ApoE3 and ApoE4), three participants in the ApoE3 group were 
excluded from the analyses, two participants because their cortisol concentrations 
differed by more than 2.5 SD from the mean, and one participant because his age 
differed by more than 2.5 SD from the mean. 
2.2. Procedure 
Participants who met the criteria were asked to attend one session that took place 
from 10:00 to 12:00 hours in a laboratory at the Faculty of Psychology.  Before the 
session, participants were asked to maintain their general habits, sleep as long as usual, 
refrain from heavy physical activity the day before the session, and not consume alcohol 
from the night before the first session. They were also instructed to drink only water, 
and not eat, smoke, take any stimulants (such as coffee, cola, caffeine, tea or chocolate), 
or brush their teeth at least 1 hour prior to the session. All participants provided written 
informed consent to participate in the study, which was conducted in accordance with 
the Declaration of Helsinki. The protocol was approved by the Research Ethics 
Committee of the University of Valencia. In this session, a neuropsychological battery 
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was administered. Additionally, participants were asked to provide two saliva samples 
(pre and post neuropsychological assessment), from which the ApoE genotype and 
cortisol levels were extracted. 
 
2.3. Neuropsychological tests 
2.3.1.Declarative memory. 
2.3.1.1. Rey Auditory Verbal Learning Test (RAVLT). The Spanish version of 
the RAVLT (Miranda & Valencia, 1997) was used.  This task consists of a target list 
(List A) of 15 neutral words repeated five times by the experimenter (trials I–V: Total 
Learning) that participants had to learn. Then, an interference list (List B) was presented 
only once, and participants had to repeat it. Participants were asked to recall the target 
list again immediately after the interference list (trial VI), and again after a delay of 20 
min (trial VII). Three outcomes were used in subsequent analyses: (i) RAVLT Total 
Learning: total number of words recalled on the first five trials (trial I to V); (ii) 
RAVLT Immediate Recall: percentage of total number of words recalled after the 
interference trial compared to the number of words recalled on trial V (trial VI/trial V x 
100); and (iii) RAVLT Delayed Recall: percentage of total number of words recalled 
after the 20-min delay compared to the number of words recalled on the immediate 
recall trial (trial VII/trial VI x 100). 
2.3.1.2. Rivermead Stories Subtest. The Story recall subtest from the Spanish 
version of the Rivermead Behavioral Memory Test (Wilson, Cockburn, &Baddeley, 
1985) was used. The experimenter read aloud two short stories, and participants had to 
recall as many memory units or ‘‘ideas’’ as possible immediately after their oral 
presentation and after a 20-min delay. Participants’ answers were audio recorded and 
corrected by an expert, and the sum of the correctly recalled ‘‘ideas’’ from the two 
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stories was calculated. From this test, two outcomes were used for the subsequent 
analysis: (i) Rivermead Immediate recall: total “ideas” recalled from the two stories 
immediately after the oral presentation and (ii) Rivermead Delayed recall: total “ideas” 
recalled from the two stories after 20 min, compared to the number of “ideas” recalled 
from the two stories immediately after the oral presentation (Delayed recall/ Immediate 
recall x100).  
2.3.2. Working memory (WM). 
2.3.2.1. Digit Span (DS). The Spanish version of the Wechsler Memory Scale III 
was administrated (Wechsler, 1997). The experimenter read aloud a series of numbers 
(from 0 to 9) of increasing length (from 2 to 9 digits) at a rate of one digit per second. 
The participant had to repeat the numbers, first in the same order (DS-Forward) and 
then in reverse order (DS-Backward). Each set length was tested twice. The test was 
finalized when the participant failed two consecutive trials of the same length. For each 
correctly repeated digit set, one point was given. Two outcomes were obtained: (i) DS-
Forward: total number of correctly recalled attempts in the same order and (ii) DS-
Backward: total number of correctly recalled attempts in the reverse order. DS-Forward 
was used as a measure of the attention and memory span component of WM, whereas 
DS-Backward was used as a measure of the executive component of WM (Conklin, 
Curtis, Katsanis, Iacono, 2000). 
2.3.2.2.Letter-number sequencing (LNS). The Spanish version of the Wechsler 
Memory Scale III was administrated (Wechsler, 1997).  The experimenter read aloud a 
series of mixed numbers (from 0 to 9) and letters (from A to Z) of increasing length 
(from 2 to 8 items). The participant had to repeat the series, ordering the numbers in 
ascending order and the letters in alphabetical order. Each set length was tested three 
times. The test was finalized when the participant failed three consecutive trials of the 
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same length. One point was given for each correctly recalled attempt. One outcome was 
obtained: LNS (total number of correctly recalled attempts). 
2.3.3. Executive Function. 
2.3.3.1.Trial-Making Test (TMT). The TMT (Reitan, 1992) consists of two 
trials, TMT-A and TMT-B, each composed of 25 circles distributed on a white sheet of 
paper. In TMT-A, the circles were numbered from 1 to 25, and the participant was 
asked to trace a line connecting the circles in numerical sequence as quickly as possible. 
TMT-B included numbers from 1 to 13 and letters from A to L, and the participant was 
instructed to alternate between numbers and letters in ascending sequence. The score 
obtained was the number of seconds required to finish each trial. Errors were pointed 
out instantly by the examiner and contributed to the score due to the additional time 
needed for corrections. Two outcomes were obtained: (i) TMT-A: total number of 
seconds required to finish the TMT-A, and (ii) TMT-B: total number of seconds 
required to finish the TMT-B. The TMT-A was used to assess attention and general 
psychomotor speed, whereas the TMT-B was used to evaluate attention-switching 
performance. 
2.3.3.2 .Stroop Color-Word Interference test. Golden’s version of the Stroop 
Color-Word Interference Test(Golden, 1978) was administered. The test is composed of 
three trials. In each trial, participants had to name as many words as possible in45 
seconds. In the first trial, participants had to read the written word (W), which was red, 
blue, or green. In the second trial, participants had to name the printed color (C), red, 
blue, or green, of the XXX letters. In the third trial, participants had to name the color of 
the printed word (red, blue, or green), which was different from the written word (red, 
blue, or green) (WC), for example, the word green printed in red color. Afterwards, the 
WC’ was calculated (WC’ = (W x C) / (W + C)). Finally, the Stroop Interference 
 12 
outcome was obtained (Stroop Interference = WC – WC’), which is a measure of the 
ability to inhibit automatic responses.  
 
2.4. Biochemical analyses 
Participants provided two saliva samples by using salivettes (Sarstedt, 
Nümbrecht, Germany), the first one at the beginning of the neuropsychological 
assessment, and the second one at the end of the session. Participants were instructed to 
keep the cotton swab in their mouths for exactly 2 min, not chew the cotton, and move 
the swab around in a circular pattern to collect saliva from all salivary glands. The 
samples were centrifuged at 3000 rpm for 5 min, resulting in a clear supernatant of low 
viscosity that was stored at -80oC until the analyses of cortisol and ApoE genotype 
determination were performed. 
2.4.1. Salivary Cortisol. 
The activity of the HPA-axis was measured by analyzing the salivary cortisol 
levels. Each sample was measured in duplicate, and each participant’s samples were 
analyzed in the same trial. The salivary cortisol samples were analyzed by a competitive 
solid phase radioimmunoassay (tube coated), using the commercial kit Spectria Cortisol 
RIA (cat. Nu 06119) from Orion Diagnostica (Espoo, Finland). Assay sensitivity was 
0.8 nmol/L, and the within- and inter-assay variation coefficients were all below 8%. 
Salivary cortisol levels were determined in the Central Research Unit of the Faculty of 
Medicine, University of Valencia (Spain). 
2.4.2. ApoE genotype determination. 
To determine the ApoE genotype, the genomic deoxyribonucleic acid (DNA) was 
isolated from the saliva by using a standard commercial extraction method (KIT 
REALPURE “SSS”). The genotype of each ApoEpolymorphism was amplified by the 
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polymerase chain reaction (PCR) using two primers: Forward 
(ACAGAATTCGCCCCGGCCTGGTACAC) and Reverse 
(TAAGCTTGGCACGCCTGTCCAAGGA). Subsequently, DNA was digested with the 
Hhal restriction enzyme. Next, DNA electrophoresis in 2% agarose gel was performed. 
Finally, after ethidium bromide staining, the DNA-banding patterns (ApoE2, ApoE3 
and ApoE4) were visualized under the ultraviolet lamp and recorded for further 
analysis. The ApoE genotype was determined at the Department of Genetics of the 
University of Valencia (Spain). 
2.5. Statistical Analysis 
Participants’ characteristics were described using percentages or means 
(standard deviation, SD) when appropriate, according to the ApoE groups (ApoE2, 
ApoE3, and ApoE4).  
To investigate whether there were differences between the ApoE groups in age, 
BMI, and SES, one-way analyses of variance (ANOVAs) were performed. Pearson’s 
Chi-square test was used to assess differences in sex and education level.  
The mean cortisol index was obtained from the cortisol levels presented at 
baseline (pre-test cortisol) and at the end of the session (post-test cortisol). Before 
statistical analyses were performed, cortisol data were checked for normal distribution 
and homogeneity of variance using Shapiro-Wilks and Levene’s test. These analyses 
revealed significant deviations in cortisol values; therefore, cortisol data were logarithm 
10 (Log10) transformed.  
To investigate whether there were differences in cognitive performance and 
mean cortisol levels among the ApoE groups, we performed one-way ANOVAs. As 
dependent variables, we used the following outcomes from the  (i) RAVLT: RAVLT 
Total Learning, RAVLT Immediate recall, and RAVLT Delayed recall, (ii) Rivermead 
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stories: Rivermead Immediate recall and Rivermead Delayed recall, (iii) DS: DS-
Forward and DS-Backward, (iv) LNS, (v) TMT: TMT-A and TMT-B, (vi) Stroop 
interference, and (vii) log10 mean cortisol. Post-hoc comparisons were performed using 
Bonferroni adjustments for the p values. 
To determine whether an association exists between mean cortisol levels and the 
different cognitive domain outcomes, first, Pearson correlational analyses were 
conducted. Then, linear regressions were performed in order to investigate these 
associations, controlling for possible confounder effects. Thus, in separate analyses for 
each cognitive domain as dependent variable, sex, age, BMI, SES, and educational level 
were included in step one as covariates, following by stepwise analysis. In step two, we 
included Log10 mean cortisol. Finally, in order to investigate whether the relationships 
between the mean cortisol levels and the different cognitive domain outcomes were 
different depending on the ApoE group, linear regression analyses were repeated with 
the sample divided into ApoE groups. 
All p values were two-tailed, and the level of significance was taken as p<0.05. 
To perform the statistical analyses, version 22.0 of SPSS was used.  
 
3. Results 
3.1. ApoE group differences in cognitive function  
One-way ANOVAs revealed significant effects of the ApoE groups on Total 
Learning from the RAVLT test (F (2, 81) = 4.191, p = .019). Post hoc analysis revealed 
significant differences between the ApoE2 and ApoE4 groups (p = .015), showing that 
the ApoE2 group obtained higher scores than the ApoE4 group. A marginal difference 
was also observed, where the ApoE2 group obtained higher scores than the ApoE3 
group (p = .065) (Figure 1). None of the other cognitive domain outcomes showed 
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significant differences among the ApoE groups. For the rest of the tests that evaluated 
declarative memory, no significant differences were found between the ApoE groups on 
immediate (F (2, 81) =1.298, p =. 279) and delayed recall (F (2, 81) =2.552 ,  p = .084) 
from the RAVLT test, or immediate (F (2, 80) = .034 , p = .967) and delayed recall (F 
(2,80) = .791 , p =.457) from the Rivermead test.  Likewise, no significant differences 
were found between the ApoE groups on the tests that evaluated working memory, such 
as the DS-Forward (F (2, 81) = 1.113, p= .333), DS-Backward (F (2, 80) = .228, p = 
.796), and LNS (F (2, 81) = .694, p = .503). Finally, no significant differences were 
found between the ApoE groups on the tests that assessed executive function attention, 
such as TMT-A (F (2, 80) =1.212, p = .303), TMT-B (F (2, 80) = .329, p = .720), and 
Stroop interference (F (2, 78) = .360, p = .699).  
 
 
Figure 1.  Mean performance on RAVLT Total Learning according to APOE group. 
One-way ANOVAs showed significant differences in declarative memory performance 
between ApoE groups (p=.019). Post hoc analysis showed better performance in the 
ApoE2 group compared to ApoE4 (*p=. 015). Although without reaching significance, 
a trend was also observed where the ApoE2 group performed better than the ApoE3 
group (p=.065). 
 




































The results showed no significant differences in mean cortisol levels among the 
ApoE groups (F (2, 80) = 1.351, p= .265) (Table 2). 
 Total  ApoE2 ApoE3 ApoE4 




5.7471 .28650 6.4377 .65110 5.7339 .31741 5.4065 .88720 
Table 2. Cortisol data for the total sample and for each ApoE group (ApoE2, ApoE3, 
and ApoE4) are represented as mean values (M) and standard error of mean (SEM). 
 
3.3. Relationship between mean cortisol levels and cognitive function 
Pearson correlational analyses showed, for the whole sample, a negative 
correlation  between mean cortisol levels during the neuropsychological session and the 
results for delayed recall on the RAVLT test (r=-.284, p = .009) and marginally with 
immediate recall on the Rivermead story test (r=-.196, p = .077). After repeating these 
analyses considering the ApoE groups, only the ApoE4 group showed a negative 
correlation between cortisol levels and delayed recall on the RAVLT (r=-.570, p = 
.021), and with  immediate recall on the Rivermead story test (r= -.609, p = .012). In 
turn, for the whole sample, a negative correlation was observed between cortisol levels 
and time performing the TMT A (r=-.230, p = .037). After repeating these analyses 
considering the ApoE groups, it was observed a negative correlation in the ApoE3 
group (r=-.309, p = .019) (Table 3). 
[Insert Table 3 about here] 
 
Regression analyses showed that, for the complete sample, higher mean cortisol 
levels during the neuropsychological session were related to worse performance on 
delayed recall on the RAVLT test (p = .009) and immediate recall on the Rivermead 
story test (p = .026). After repeating these analyses considering the ApoE groups, this 
relationship was significant for the ApoE4 group (p = .015 and p = .008, respectively). 
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In turn, for the whole sample, a trend was observed where higher cortisol levels were 
associated with lower times performing the TMT A (p = .060) and, therefore, better 
performance. After repeating these analyses considering the ApoE groups, this 
relationship was significant for the ApoE3 group (p = .024). None of the other 
associations were significant (all p> .098) (Table 4). 
[Insert Table 4 about here] 
 
4. Discussion 
The aims of the present study were to examine (i) the differences between the 
ApoE groups in cognitive performance (i.e. declarative and working memory, attention, 
and executive function) and cortisol levels during the neuropsychological assessment 
and (ii) the association between cortisol levels and cognitive performance in healthy 
older people, taking into account the ApoE group (i.e. ApoE2, ApoE3, and ApoE4). To 
do so, we explored these possible relationships, firstly in the complete sample and then 
for each ApoE group. The results showed significant differences among the ApoE 
groups only on declarative memory, specifically on learning ability (RAVLT Total 
Learning). Moreover, for the complete sample, higher cortisol levels were related to 
worse performance on declarative memory (delayed recall on the RAVLT and 
immediate recall on the Rivermead tests). After performing these analyses taking into 
account the ApoE group, this association was only significant for the ApoE4 group. On 
the other hand, for the whole sample, higher cortisol levels were marginally related to 
better attention (i.e. lower times performing the TMT-A). After splitting the sample 
considering the ApoE groups, this relationship was significant only for the ApoE3 
group. 
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Our findings demonstrated an association between declarative memory, 
specifically learning ability, and the ApoE genotype, where subjects carrying the ApoE2 
allele performed better than those with ApoE4 and ApoE3. Other studies with older 
people have also found similar results (Deary et al., 2004; Helkala et al., 1995; 1996; 
Kang et al., 2005; Wilson et al., 2002). Helkala et al. (1995; 1996) also observed that 
the ApoE2 group was associated with better learning ability than the ApoE3 and ApoE4 
groups.  Moreover, in a review, Wisdom et al. (2011) reported that the ApoE2 group 
performed better on declarative memory than theApoE4 group. Thus, our results, 
coinciding with other studies, support the idea that the ApoE2 allele provides an 
advantage on declarative memory performance, compared to the ApoE3 and ApoE4 
alleles.  
No differences were found between the ApoE3 and ApoE4 groups on declarative 
memory performance. This finding was surprising because we expected worse 
performance on declarative memory in the ApoE4 group, as in previous studies (Honea 
et al., 2009; Laukka et al., 2013; Nilsson et al., 2006; Small et al., 2004; Wisdom et al., 
2011). However, some studies have reported that cognitive deficits related to the ApoE4 
allele were due to preclinical cases of AD, and that this association disappeared when 
possible dementia cases were removed (Batterham, Bunce, Cherbuin, & Christensen, 
2013;Salo et al., 2001). It is important to note that, in our study, all participants scored 
28 on the MEC, indicating no cognitive impairment. In addition, participants underwent 
very restrictive criteria compared to other studies, and so a very healthy sample was 
obtained. Therefore, in our sample of non-demented and non-stressed healthy elderly 
people, there would be no differences between the ApoE3 and ApoE4 groups. 
Moreover, in our study, due to the small number of ApoE4 homozygous (E4/E4=2) and 
heterozygous (E3/E4=14) participants, they were grouped into the broad category of the 
 19 
ApoE4 group, leading to an overrepresentation of the ApoE4 heterozygous group. In a 
meta-analysis, Wisdom et al. (2011) found that people with the ApoE4 homozygote 
performed significantly worse than ApoE4 non-carriers on declarative memory. 
However, no significant differences were found between ApoE4 heterozygote and 
ApoE4 non-carriers. Thus, our findings are consistent with this meta-analysis, where no 
significant differences where observed between the ApoE4 and the ApoE3 groups on 
declarative memory tasks. Finally, few studies have explored the effect of the ApoE4 
allele taking into account the ApoE2 allele effect. In most studies, the ApoE2 allele, 
associated with better performance, has been grouped with the ApoE3 allele under the 
broad category of “ApoE4 non-carriers”. Therefore, this may have led to an 
overestimation of the ApoE3 and an underestimation of the ApoE4 allele performance. 
Thus, these considerations would reinforce our results showing no differences in 
cognitive function between the ApoE3 and the ApoE4 groups. 
On the other hand, unexpectedly, no differences in cortisol levels were found 
among the ApoE groups. Some studies have suggested that the relationship between the 
ApoE4 allele and higher cortisol levels might appear only in AD and dementia (Fiocco 
et al., 2008; Gil-Bea et al., 2010), which would explain that this association was not 
observed in our cognitively healthy sample.    
Regarding the second aim of the present study, as expected, higher cortisol 
levels were associated with worse declarative memory performance, both immediate 
and delayed recall, in the complete sample (Lee et al., 2007; Li et al., 2006; 
MacLullichet al., 2005; Seeman, McEwen, Singer, Albert, & Rowe, 1997;Vedhara, 
Hyde, Gilchrist, Tytherleigh, & Plummer, 2000; Wright, Kunz-Ebrecht, Iliffe, Foese, & 
Steptoe, 2005) and in the ApoE4 group (Gerretsein et al., Singh-Manoux et al., 2014). 
Previous studies found an association between the ApoE4 allele, a faster decline in 
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verbal fluency, and a flatter diurnal slope, that is, higher evening and lower morning 
cortisol (Gerritsen et al., 2011; Singh-Manoux et al., 2014). In turn, as in our study, Lee 
et al. (2008) measured cortisol levels during the cognitive assessment and observed that, 
whereas higher cortisol was associated with lower cognitive performance, the slopes 
were steeper in the ApoE4 group. Thus, in line with our results, they suggested that the 
ApoE4 allele increases the aging brain’s vulnerability to adverse effects of cortisol.  
Finally, higher cortisol levels were associated with lower time performing the 
TMT-A and, therefore, better attention, in the total sample and in the ApoE3 group. 
Glucocorticoid receptors are widely distributed in the hippocampus and in the prefrontal 
cortex, which are involved in declarative memory and attention and executive function, 
respectively (Lupien et al., 1999). Whereas some studies found that lower cortisol levels 
were related to worse attentional performance (Pulopulos et al., 2015; Vedhara et al., 
2000), other  studies reported an association between higher cortisol levels and worse 
attention and processing speed (Beluche et al., 2010; Fonda, Bertrand, O'Donnell, 
Longcope, &McKinlay, 2005; Franz et al., 2011;Lee et al., 2007; MacLullich et al., 
2005). In addition, Lupien et al. (1999) observed an inverted-U pattern between cortisol 
and working memory performance that has an attentional component (Mirsky, Anthony, 
Duncan, Ahearn, & Kellam, 1991) and is also mediated by prefrontal cortex 
functioning. They found that, whereas low doses of increased corticosteroids would 
improve performance, high doses would impair it. Therefore, in our study with elderly 
people, higher cortisol levels (Lupien, Maheu, Tu, Fiocco, &Schramek, 2007) may have 
improved attentional performance. To our knowledge, no studies have found this 
association in the ApoE3 group. By contrast, Gerritsen et al. (2011) and Lee et al. 
(2008) observed that the ApoE4 group was more vulnerable to the detrimental effects of 
cortisol on cognitive functioning. Therefore, the positive relationship between cortisol 
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and attention in the ApoE3 group may indicate that they are less vulnerable to the 
negative effects of corticosteroids on attention. 
 Some limitations should be considered. First, it is important to note the 
correlational nature of the results, and so we cannot claim causal relationships. In 
addition, due to the unequal distribution of the three ApoE alleles and the low frequency 
of the ApoE2 and ApoE4 alleles in the population, in our sample the number of 
participants in each ApoE group differed, and the sample size for the ApoE2 and the 
ApoE4 groups was small. Therefore, it is possible that due to the small sample sizes 
some of the expected results that had been hypothesized have not been observed. Thus, 
a larger sample size would be necessary to increase the statistical power. Nevertheless, 
it is important to highlight the effort that has been made in this study to separate and 
compare the three allelic variations and study their relationship with a wide range of 
cognitive domains and the HPA axis. In addition, the strict exclusion criteria make it 
possible to control the effect of confounding variables. Finally, also due to the small 
sample size, sex differences have not been taken into account, although several studies 
with healthy elderly people have shown that women outperform men on verbal memory 
(Zhang, Zhou, Wang, Zhang & Study, 2017; Munro et al., 2012), whereas men perform 
better on visuospatial ability (Munro et al.,2012). Moreover, there is evidence that 
women are at higher risk for AD than men (Farrer et al, 1997), and so it seems 
necessary to study sex differences in the influence of the ApoE gene on cognitive 
function. Whereas some studies have reported a higher ApoE4-associated risk of AD in 
women than in men (Corrada et al., 2013; Farrer et al., 1997), others found the opposite 
relationship (Qiu, Kivipelto, Agüero-Torres, Winblad, & Fratiglioni, 2004) or no 
association (Yip, Brayne, Easton, & Rubinsztein, 2002). Thus, future studies with larger 
samples are needed to shed light on this pending issue. 
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In summary, our results show that, in healthy older people, the ApoE2 allele 
may have a protective effect on declarative memory, specifically learning ability. 
Additionally, although the ApoE4 allele would not have a negative effect on cognitive 
function compared to ApoE3, high cortisol levels would be especially detrimental to 
declarative memory in this group, compared to the ApoE2 and ApoE3 groups. Thus, the 
ApoE4 allele could add greater vulnerability to the adverse effects of HPA axis 
dysregulation on declarative memory during aging.  
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Table 3.Pearson correlational analyses between log 10 mean cortisol and cognitive outcomes. Values in bold represent significant or marginal 



























LNS TMT-A TMT-B Stroop 
Interfe- 
rence 
Total  r -.126 .069 -.284 -.196 -.006 .020 .006 -.010 -.230 .033 .024 
 p .256 .533 .009 .077 .956 .858 .958 .928 .037 .768 .830 
ApoE2 r -.254 -.020 .223 -.518 -.126 .233 .281 -.454 -.024 -.036 .044 
 p .510 .960 .564 .153 .747 .546 .464 .220 .951 .926 .910 
ApoE3 r -.212 -.019 -.185 -.027 -.150 .163 .111 .026 -.309 -.028 -.070 
 p .110 .885 .165 .841 .265 .222 .409 .847 .019 .837 .611 
ApoE4 r -.119 .314 -.570 -.609 .298 -.368 -.413 -.075 -.003 .361 .379 




Table 4. Regression analyses with cortisol as predictor and cognitive outcomes as dependent variables. Values in bold represent significant or 
marginal values of p 
 


























Total AdjR2 .003 -.005 .072 .227 -.013 .364 .163 .285 .085 .193 -.012 
 Beta -.125 .085 -.289 -.224 -.016 -.015 -.022 -.030 -.206 .062 .033 
 p .267 .452 .009 .026 .888 .867 .828 .751 .060 .544 .771 
ApoE2 AdjR2 -.160 -.153 -.121 -.047 -.071 -.111 -.127 .551 -.088 -.167 -.124 
 Beta -.073 .109 .197 -.320 -.287 .218 .185 -.394 .260 -.003 .192 
 p .863 .798 .639 .440 .491 .605 .662 .189 .535 .995 .649 
ApoE3 AdjR2 .032 -.018 .019 .102 .009 .390 .180 .376 .074 .056 -.015 
 Beta -.221 -.004 -.190 -.086 -.163 .091 .124 -.038 -.302 .015 -.063 
 p .098 .974 .156 .505 .229 .394 .314 .723 .024 .909 .653 
ApoE4 AdjR2 .161 .034 .548 .605 .261 .640 .280 -.065 .190 .068 .083 
 Beta -.032 .314 -.491 -.518 .221 .010 -.250 -.075 -.096 .361 .379 
 p .895 .237 .015 .008 .343 .956 .303 .783 .690 .170 .147 
